QC
TMO icon

Quadrature Capital’s Thermo Fisher Scientific TMO Stock Holding History

Quadrature Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71M Buy
+15,383
New +$7.38M 0.07% 215
2025
Q3 		– Sell
-10,282
Closed -$4.17M – 1488
2025
Q2 		$4.17M Sell
10,282
-47,565
-82% -$19.9M 0.07% 201
2025
Q1 		$28.8M Buy
57,847
+46,817
+424% +$25.4M 0.64% 30
2024
Q4 		$5.74M Buy
11,030
+1,476
+15% +$812K 0.12% 165
2024
Q3 		$5.91M Sell
9,554
-68,484
-88% -$40.5M 0.13% 130
2024
Q2 		$43.1M Buy
+78,038
New +$44.7M 0.72% 34
2023
Q3 		– Sell
-41,577
Closed -$21.7M – 1262
2023
Q2 		$21.7M Buy
41,577
+38,551
+1,274% +$20.8M 0.47% 54
2023
Q1 		$1.74M Sell
3,026
-10,913
-78% -$6.15M 0.05% 304
2022
Q4 		$7.68M Sell
13,939
-15,996
-53% -$8.48M 0.23% 108
2022
Q3 		$15.2M Buy
29,935
+29,448
+6,047% +$16.5M 0.49% 53
2022
Q2 		$265K Sell
487
-8,605
-95% -$4.74M 0.01% 566
2022
Q1 		$5.37M Buy
+9,092
New +$5.22M 0.22% 101
2021
Q2 		– Sell
-46,813
Closed -$21.4M – 1229
2021
Q1 		$21.4M Buy
46,813
+45,776
+4,414% +$21.8M 1.04% 17
2020
Q4 		$483K Buy
+1,037
New +$486K 0.02% 494
2020
Q2 		– Sell
-8,628
Closed -$2.44M – 810
2020
Q1 		$2.44M Buy
8,628
+7,028
+439% +$2.22M 0.58% 36
2019
Q4 		$519K Buy
+1,600
New +$485K 0.02% 345
2019
Q1 		– Sell
-13,601
Closed -$3.04M – 703
2018
Q4 		$3.04M Buy
13,601
+8,711
+178% +$2.04M 0.56% 42
2018
Q3 		$1.19M Buy
+4,890
New +$1.12M 0.1% 227
2017
Q4 		– Sell
-15,965
Closed -$3.02M – 664
2017
Q3 		$3.02M Sell
15,965
-636
-4% -$115K 0.38% 62
2017
Q2 		$2.9M Sell
16,601
-9,548
-37% -$1.6M 0.22% 102
2017
Q1 		$4.02M Sell
26,149
-41,097
-61% -$6.28M 0.29% 89
2016
Q4 		$9.49M Buy
+67,246
New +$9.91M 0.3% 86
2016
Q3 		– Sell
-110,488
Closed -$16.3M – 735
2016
Q2 		$16.3M Buy
+110,488
New +$16.3M 1.21% 14

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Quadrature Capital's TMO Position: Q2 2026 in Review

Quadrature Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 15,383 shares worth $7.71M. The stake represents 0.07% of the portfolio and ranks #215 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in TMO as recently as Q2 2025.

Quadrature Capital first reported a position in TMO in Q2 2016 and has held it in 23 quarters since. The position peaked at $43.1M in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Quadrature Capital held 15,383 shares of Thermo Fisher Scientific worth $7.71M as of Q2 2026.
  • Thermo Fisher Scientific was a new Quadrature Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 0.07% of Quadrature Capital's portfolio in Q2 2026, its #215 holding.
  • Quadrature Capital first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 23 quarters since.
  • Quadrature Capital's Thermo Fisher Scientific position peaked at $43.1M in Q2 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.